Press Releases - 2023-11-29

Date	Title	Company
29-Nov-2023	Qnovia, Inc. announces positive results from first-in-human pharmacokinetic and safety study of lead asset QN-01, a prescription inhaled smoking cessation therapy	Qnovia
29-Nov-2023	Medacta further expands in Rancate, Switzerland, doubling its production capability to support the future growth	Medacta Group SA
29-Nov-2023	PureTech Founded Entity Karuna Therapeutics Announces U.S. Food and Drug Administration Accepts New Drug Application for KarXT for the Treatment of Schizophrenia	PureTech
29-Nov-2023	Oxford BioTherapeutics Announces Partner Boehringer Ingelheim Received U.S. FDA Fast Track Designation for BI 764532 for the Potential Treatment of Advanced or Metastatic Large-Cell Neuroendocrine Carcinoma of the Lung	Oxford BioTherapeutics
29-Nov-2023	Stanhope and Cadillac Fairview appoint Morgan Lovell to build new lab space at White City Place for life sciences companies	Stanhope and Cadillac Fairview
29-Nov-2023	Almac Discovery and Queen’s University launch state-of-the-art Chemoproteomics facility in Belfast	Almac Discovery and Queen’s University
29-Nov-2023	Spexis Provides Update Regarding Debt-Restructuring Moratorium	Spexis AG
29-Nov-2023	GILEAD SCIENCES AWARDS OVER US$1.5 MILLION TO STRENGTHEN SUPPORT FOR COMMUNITY-LED HIV PROJECTS IN ASIA PACIFIC	GILEAD SCIENCES
29-Nov-2023	Nanologica Receives Order of Purification Media Worth Approx. MSEK 3.6	Nanologica
29-Nov-2023	Kyowa Kirin Responds to NICE’s Publication of Appraisal Consultation Document for CRYSVITA® (Burosumab), for Treatment of Rare Disease X-Linked Hypophosphataemia (XLH) in Adults1	Kyowa Kirin
29-Nov-2023	RetinAI Joins Forces with Stephen J. Ryan Initiative for Macular Research (RIMR) AMD Consortium to Forge a Global Retinal Imaging initiative Targeting Research in AMD	RetinAI
29-Nov-2023	Leading industry surveys demonstrate continued growth in the UK’s cell and gene therapy sector	The Cell and Gene Therapy Catapult (CGT Catapult),
29-Nov-2023	Eye-safe laser technology to diagnose traumatic brain injury	University of Birmingham
29-Nov-2023	Valo Therapeutics Announces Regulatory Approval to Expand Phase I Immuno-oncology Trial into Sarcoma	Valo Therapeutics
29-Nov-2023	RHYTHM AI announces new STAR Apollo Mapping System to feature at Rhythm Interventions Online (RIO) Congress	RHYTHM AI
29-Nov-2023	MIMETAS and Yamaha Motor Sign Joint Marketing Agreement to Advance Automated Human Disease Model Applications for Drug Development	MIMETAS and Yamaha Motor
29-Nov-2023	GILEAD SCIENCES AWARDS OVER US$1.5 MILLION TO STRENGTHEN SUPPORT FOR COMMUNITY-LED HIV PROJECTS IN ASIA PACIFIC	GILEAD SCIENCES
29-Nov-2023	Hovione expands nasal drug delivery capabilities with the development of nasal powder delivery device technology in collaboration with IDC	Hovione
29-Nov-2023	Acrometa Posts Record Revenue of S$69.5 Million for FY2023, Continues to Pursue New Opportunities in Co-Working Lab Space Business	AcroMeta Group Limited
29-Nov-2023	Mainz Biomed’s Presentation at the 35th Annual Piper Sandler Healthcare Conference to be Made Available via Webcast	Mainz BioMed N.V.